BRIEF published on 01/21/2025 at 21:05, 1 year 8 months ago Fundraising of €0.25 million by Néovacs Fundraising Shareholder Dilution Néovacs OCEANE-BSA Kinoid® Research
BRIEF published on 01/21/2025 at 21:05, 1 year 8 months ago Levée de fonds de 0,25 M€ par Néovacs Levée De Fonds Néovacs OCEANE-BSA Dilution Actionnaire Recherche Kinoïde®
PRESS RELEASE published on 01/21/2025 at 21:00, 1 year 8 months ago Levée de fonds de 0,25 MEUR Néovacs annonce une levée de fonds de 0,25 M€ par l'émission d'OCEANE-BSA pour financer la recherche sur les allergies et les investissements en BioTech et MedTech Biotech MedTech Levée De Fonds Néovacs OCEANE-BSA
BRIEF published on 01/15/2025 at 20:05, 1 year 8 months ago Adjustment of the nominal value at Neovacs Investment Capital Reduction Nominal Value Néovacs Stock Market Shares
BRIEF published on 01/15/2025 at 20:05, 1 year 8 months ago Ajustement de la valeur nominale chez Néovacs Investissement Valeur Nominale Néovacs Actions Boursières Réduction Capital
PRESS RELEASE published on 01/15/2025 at 20:00, 1 year 8 months ago Ajustement de la valeur nominale Néovacs réduit la valeur nominale de son action de 1 euro à 0,50 euro, suite à une réduction de capital motivée par des pertes. La société française développe des thérapies pour maladies inflammatoires Biopharmaceutique Réduction De Capital Maladies Inflammatoires Valeur Nominale Néovacs
BRIEF published on 12/18/2024 at 08:35, 1 year 9 months ago Levée de fonds par Néovacs Biotechnologie Levée De Fonds Dilution Néovacs OCEANE-BSA
BRIEF published on 12/18/2024 at 08:35, 1 year 9 months ago Fundraising by Neovacs Biotechnology Fundraising Dilution Néovacs OCEANE-BSA
PRESS RELEASE published on 12/18/2024 at 08:30, 1 year 9 months ago Levée de fonds de 0,25 MEUR Néovacs annonce une levée de fonds de 0,25 M€ pour financer le programme de recherche Kinoïde® sur les allergies et renforcer les investissements en BioTech et MedTech Biotech Levée De Fonds Néovacs Kinoïde® Allergies
BRIEF published on 09/18/2024 at 20:05, 2 years ago Fundraising of €0.25 million by Néovacs Biotechnology Fundraising Investment Dilution OCEANE-BSA
Published on 09/26/2026 at 01:00, 5 hours 50 minutes ago Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 5 hours 50 minutes ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 8 hours 35 minutes ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 13 hours 20 minutes ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 15 hours 50 minutes ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/26/2026 at 00:01, 6 hours 48 minutes ago Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 12 hours 20 minutes ago 029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:00, 12 hours 50 minutes ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Published on 09/25/2026 at 17:30, 13 hours 20 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 09/25/2026 (French only)
Published on 09/25/2026 at 17:45, 13 hours 5 minutes ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 13 hours 10 minutes ago Availability of the 2026 half-year financial report
Published on 09/25/2026 at 17:40, 13 hours 10 minutes ago Mise à disposition du rapport financier semestriel 2026
